Cormorant Asset Management, LP - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CEREW and the CUSIP is 15678U102. A total of 25 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q2 2021$278,000
-50.6%
19,316
-85.5%
0.01%
-30.8%
Q1 2021$563,000
-25.2%
133,3310.0%0.01%
-27.8%
Q4 2020$753,000133,3310.02%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q2 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 72,466$312,0000.11%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 459,215$1,979,0000.08%
Monashee Investment Management LLC 99,998$431,0000.07%
Governors Lane LP 196,034$845,0000.06%
SPHERA FUNDS MANAGEMENT LTD. 166,332$702,0000.05%
Context Capital Management, LLC 82,868$357,0000.04%
EQUITEC SPECIALISTS, LLC 35,825$154,0000.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 166,666$718,0000.02%
RA Capital Management 233,333$1,006,0000.02%
Logos Global Management LP 33,333$144,0000.01%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders